Disease Control and Prevention Vaccine Market – Insights
Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide. According to European Centre for Disease Prevention and Control (ECDC), pertussis and invasive pneumococcal disease account for over 50% of vaccine preventable disease and over 60% of deaths. The completion immunization schedule from infant to adulthood significantly reduces burden of vaccine preventable disease. According to World Health Organization (WHO), 2018 factsheet, immunization prevents 2 to 3 million deaths annually. Furthermore, around 1.5 million deaths can be prevented by improving vaccine coverage. Several vaccine manufacturers’ work in partnership with civil society organization such as World Health Organization (WHO), United Nations Children's Fund (UNICEF), and Global Alliance for Vaccines and Immunisation (GAVI) Alliance to improve their vaccination program for reducing number of patient suffering from diseases
The global disease control and prevention vaccine market was valued at US$ 41.12 billion in 2017 and is expected to witness a CAGR of 12.1 % over the forecast period (2017–2025).
Global Disease Control and Prevention Vaccine Market, By Product Type
Source: Coherent Market Insights Analysis (2018)
High Prevalence of Infectious Disease is Expected to Drive Growth of the Disease Control and Prevention Vaccine Market
High prevalence and increasing incidence of infectious disease are the major factors driving growth of the disease control and prevention vaccine market. According to the study published in journal Lancet Infectious Disease, around 54,984,661 cases of 45 infectious diseases were reported with average yearly incidence 417·98 per 100?000 in china between January 2004 and December 2013. Furthermore, Hepatitis B and tuberculosis has high incidence rate of 81.57 and 80.33 per 100,000, respectively. Moreover, World Health Organization (WHO) estimated 212 million malaria cases globally in 2015 with highest incidence in African regions.
Furthermore, the vaccines manufactured by novel technologies such as recombinant technology or cell-based vaccine production is decreasing the gap between demand and supply, which is expected to drive growth of the disease control and prevention vaccine market. For instance, in 2013, Protein Science Corporation received FDA approval for Flubok Trivalent Vaccine, produced by recombinant technology in the U.S. Moreover, in 2016, Seqirus received US FDA approval for Flucelvax Quadrivalent, cell-culture derived influenza vaccine.
Increasing Governmental Initiatives for Immunization Programs is Driving Growth of the Disease Control and Prevention Vaccine Market
Governmental and non-governmental organization partners are working together to provide better immunization to population for complete disease eradication. For instance, the Global Polio Eradication Initiative was a public-private partnership between five governmental agencies - the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC), the United Nations Children’s Fund (UNICEF) and the Bill & Melinda Gates Foundation, aiming at polio eradication worldwide. The program was funded US$ 15 billion in the period 1988 - 2017, provided by public and private donors and 2013 - 2019 requirement was projected to US$ 7 billion. Furthermore, organization such as Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH) have partnered with the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) to support development of advanced influenza vaccines. Such governmental approaches are expected to augment the growth of global disease control and prevention vaccine market over the forecast period (2017-2025). However, high cost of vaccine development is expected to restrain growth of the disease control and prevention vaccine market.
According to Access to Medicine Foundation index, 2017, vaccine market is dominated by four major players, collectively referred as 'big four': GSK, Merck & Co., Inc., Pfizer, and Sanofi. Big four contribute to 80% of the global vaccine revenue. Players vary significantly by portfolio and pipeline size. Other major players operating in market include AstraZeneca PLC, Sinovac Biotech Ltd., Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., and Daiichi Sankyo.
Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
Market Dynamics
The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.
Key features of the study:
- This report provides in-depth analysis of the disease control and prevention vaccine market and its Type, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global disease control and prevention vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
- The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
- Global Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Global Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Global Disease Control and Prevention Vaccine Market, By Route of Administration:
- Global Disease Control and Prevention Vaccine Market, By Age Group:
- Global Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Global Disease Control and Prevention Vaccine Market, By Region:
- North America
- U.S.
- U.S. Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- U.S. Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- U.S. Disease Control and Prevention Vaccine Market, By Route of Administration:
- U.S. Disease Control and Prevention Vaccine Market, By Age Group:
- U.S. Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Canada
- Canada Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Canada Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Canada Disease Control and Prevention Vaccine Market, By Route of Administration:
- Canada Disease Control and Prevention Vaccine Market, By Age Group:
- Canada Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Europe
- U.K.
- U.K. Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- U.K. Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- U.K. Disease Control and Prevention Vaccine Market, By Route of Administration:
- U.K. Disease Control and Prevention Vaccine Market, By Age Group:
- U.K. Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Germany
- Germany Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Germany Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Germany Disease Control and Prevention Vaccine Market, By Route of Administration:
- Germany Disease Control and Prevention Vaccine Market, By Age Group:
- Germany Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Italy
- Italy Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Italy Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Italy Disease Control and Prevention Vaccine Market, By Route of Administration:
- Italy Disease Control and Prevention Vaccine Market, By Age Group:
- Italy Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- France
- France Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- France Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- France Disease Control and Prevention Vaccine Market, By Route of Administration:
- France Disease Control and Prevention Vaccine Market, By Age Group:
- France Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Spain
- Spain Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Spain Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Spain Disease Control and Prevention Vaccine Market, By Route of Administration:
- Spain Disease Control and Prevention Vaccine Market, By Age Group:
- Spain Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Russia
- Russia Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Russia Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Russia Disease Control and Prevention Vaccine Market, By Route of Administration:
- Russia Disease Control and Prevention Vaccine Market, By Age Group:
- Russia Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Europe
- Rest of Europe Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Europe Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Europe Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Europe Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Europe Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Asia-Pacific
- China
- China Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- China Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- China Disease Control and Prevention Vaccine Market, By Route of Administration:
- China Disease Control and Prevention Vaccine Market, By Age Group:
- China Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- India
- India Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- India Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- India Disease Control and Prevention Vaccine Market, By Route of Administration:
- India Disease Control and Prevention Vaccine Market, By Age Group:
- India Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Japan
- Japan Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Japan Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Japan Disease Control and Prevention Vaccine Market, By Route of Administration:
- Japan Disease Control and Prevention Vaccine Market, By Age Group:
- Japan Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- ASEAN
- ASEAN Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- ASEAN Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- ASEAN Disease Control and Prevention Vaccine Market, By Route of Administration:
- ASEAN Disease Control and Prevention Vaccine Market, By Age Group:
- ASEAN Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Australia
- Australia Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Australia Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Australia Disease Control and Prevention Vaccine Market, By Route of Administration:
- Australia Disease Control and Prevention Vaccine Market, By Age Group:
- Australia Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- South Korea
- South Korea Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- South Korea Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- South Korea Disease Control and Prevention Vaccine Market, By Route of Administration:
- South Korea Disease Control and Prevention Vaccine Market, By Age Group:
- South Korea Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Asia Pacific
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Latin America
- Brazil
- Brazil Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Brazil Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Brazil Disease Control and Prevention Vaccine Market, By Route of Administration:
- Brazil Disease Control and Prevention Vaccine Market, By Age Group:
- Brazil Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Mexico
- Mexico Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Mexico Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Mexico Disease Control and Prevention Vaccine Market, By Route of Administration:
- Mexico Disease Control and Prevention Vaccine Market, By Age Group:
- Mexico Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Latin America
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Middle East
- GCC
- GCC Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- GCC Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- GCC Disease Control and Prevention Vaccine Market, By Route of Administration:
- GCC Disease Control and Prevention Vaccine Market, By Age Group:
- GCC Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Israel
- Israel Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Israel Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Israel Disease Control and Prevention Vaccine Market, By Route of Administration:
- Israel Disease Control and Prevention Vaccine Market, By Age Group:
- Israel Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Middle East
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Africa
- North Africa
- North Africa Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- North Africa Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- North Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
- North Africa Disease Control and Prevention Vaccine Market, By Age Group:
- North Africa Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Central Africa
- Central Africa Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Central Africa Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Central Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
- Central Africa Disease Control and Prevention Vaccine Market, By Age Group:
- Central Africa Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- South Africa
- South Africa Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- South Africa Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- South Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
- South Africa Disease Control and Prevention Vaccine Market, By Age Group:
- South Africa Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Company Profiles
- GlaxoSmithKline plc (GSK) *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co. Inc.
- Sanofi
- AstraZeneca PLC
- Pfizer, Inc.
- Serum Institute of India Pvt. Ltd.
- Sinovac Biotech Ltd.
- Astellas Pharma Inc.
- Daiichi Sankyo
“*” marked represents similar segmentation in other categories in the respective section.
